Lok, A., Mocquard, J., Bourcier, J., Redelsperger, L., Bonnet, A., Chauvin, C., Thomaré, P., Mahé, B., Touzeau, C. and Moreau, P. (2014) “Subcutaneous bortezomib incorporated into the bortezomib-thalidomide-dexamethasone regimen as part of front-line therapy in the context of autologous stem cell transplantation for multiple myeloma”, Haematologica. Pavia, Italy, 99(3), pp. e33-e34. doi: 10.3324/haematol.2013.100396.